SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)

NAActive, not recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

October 9, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Kidney StoneUrolithiasisNephrolithiasisRenal CalculiKidney CalculiNephrolithUrinary Calculi
Interventions
DEVICE

Break Wave extracorporeal lithotripsy

The Break Wave device will be used to exert a low amplitude burst of ultrasound waves focused at the kidney stone. The primary components of the device include an ultrasound imaging system and a therapy probe driven by a high voltage generator. The probe will be placed on the patient's skin, the stone located via diagnostic ultrasound and up to 30 minutes of therapy will be delivered to the stone. The therapy probe accommodates coaxial alignment of an ultrasound imaging probe for treatment guidance.

Trial Locations (10)

18103

Lehigh Valley Health Network, Allentown

37232

Vanderbilt University, Nashville

60611

Northwestern Medicine, Chicago

92037

University of California- San Diego, San Diego

94143

University of California - San Francisco, San Francisco

95051

Kaiser Permanente, Santa Clara

98195

University of Washington, Seattle

T6G 1Z1

University of Alberta, Edmonton

Unknown

University of British Columbia, Vancouver

M5C 2T2

St. Michael's Hospital, University of Toronto, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

SonoMotion

INDUSTRY

NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) | Biotech Hunter | Biotech Hunter